Immediate, Remote Smoking Cessation Intervention in Participants Undergoing a Targeted Lung Health Check: Quit Smoking Lung Health Intervention Trial, a Randomized Controlled Trial.

Authors:
Williams PJ; Philip KEJ; Gill NK; Flannery D; Buttery S and 9 more

Journal:
Chest

Publication Year: 2022

DOI:
10.1016/j.chest.2022.06.048

PMCID:
PMC9899638

PMID:
35932889

Journal Information

Full Title: Chest

Abbreviation: Chest

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: N. S. H. is chair of Action on Smoking and Health and medical director of Asthma+Lung UK; A. A. L. is a trustee of Action on Smoking and Health. None declared (P. J. W., K. E. J. P., N. K. G., D. F., S. B., E. C. B., A. D., S. V. K., J. A., J. D., M. C., K. M.)."

Evidence found in paper:

"Funding/Support This work was supported by RM Partners, West London Cancer Alliance, hosted by The Royal Marsden NHS Foundation Trust."

Evidence found in paper:

"The study was approved by the South Central—Oxford C Research Ethics Committee and the Health Research Authority (Reference: 18/SC/0236). The requirement for individual consent was waived by the ethics committee because obtaining this would itself have been an intervention and would have influenced outcomes in the control group. The initial QuLIT 1 and the amended study reported here, QuLIT 2, were registered prospectively online (ISRCTN12455871)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025